Find News

Filter articles

Showing 151 to 160 of 3629 results

Galderma sues Lupin over Oracea generic

US07-12-2021Alex Baldwin

Galderma Laboratories has sued Lupin Pharmaceuticals alleging that it plans to manufacture and sell a generic version of Oracea prior to the expiration of key patents.

J&J secures injunction against medical device counterfeiter


Johnson & Johnson’s subsidiary Ethicon has obtained a permanent injunction against counterfeiters selling fake versions of Surgicel, an absorbable haemostat used to control bleeding during surgery.

BGI hit with $8m damages bill in patent dispute with Illumina

02-12-2021Muireann Bolger

Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.

Moderna exposed after losing COVID-19 vaccine patent decision

02-12-2021Muireann Bolger

Moderna has failed to reverse an unfavourable ruling related to its COVID-19 vaccine technology, after the US Court of Appeals for the Federal Circuit upheld the validity of a patent owned by Arbutus Biopharma.

Fed Circuit split decision denies Biogen’s bid to revive MS drug patent


The US Court of Appeals for the Federal Circuit has refused Biogen’s attempt to revive a key patent for its multiple sclerosis drug Tecfidera (dimethyl fumarate), leaving Mylan’s successful challenge intact. 

Biofrontera settles patent dispute with Dusa over skin treatment

US30-11-2021Muireann Bolger

A US subsidiary of German skin treatment company Biofrontera has resolved its dispute with Dusa Pharmaceuticals, on the eve of a trial over patents covering a light therapy used to treat skin conditions, called BLU-U.

Fed Circ says Indivior patent was anticipated

US30-11-2021Alex Baldwin

The US Court of Appeals for the Federal Circuit has affirmed a US Patent Trial and Appeal Board decision that held that claims of a patent for dissolvable films containing therapeutic agents were anticipated.

Omicron variant delays COVID-19 IP waiver debate


The World Trade Organization has postponed its ministerial conference indefinitely, potentially ending the opportunity for countries to agree an IP waiver for COVID-19 vaccines this year.

Court denies Sun Pharma’s bid to avoid trial

India, US25-11-2021

Sun Pharma’s bid to avoid facing a trial over allegations of antitrust behaviour by an Indian drugmaker it acquired has been denied by a Massachusetts court.

Fed Circ invaded jury’s role in Repatha case, says Amgen

US25-11-2021Muireann Bolger

Amgen has urged the US Supreme Court to wade into its legal wrangle with Sanofi and Regeneron Pharmaceuticals over patents covering a cholesterol drug, Repatha.

Showing 151 to 160 of 3629 results